Loading...
Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
Protease proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of LDL cholesterol clearance and has been associated with cardiovascular risk. PCSK9 inhibitors increase in vivo circulating endothelial progenitor cells (EPCs), a subtype of immature cells involved in ongoing endothelial...
Na minha lista:
Udgivet i: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group UK
2021
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8102605/ https://ncbi.nlm.nih.gov/pubmed/33958634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88941-x |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|